APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urinary and Pelvic Floor Health Solution

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Urinary and Pelvic Floor Health Solution Market Outlook and Growth Opportunities 2026

2 May 2026197 pages

Choose your research edition.

Industry ResearchUrinary and Pelvic Floor Health Solution Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Urinary and Pelvic Floor Health Solution Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Urinary and Pelvic Floor Health Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urinary and Pelvic Floor Health Solution Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Urinary and Pelvic Floor Health Solution Market Analysis and Forecast 2026-2032244 pages · $4,950 USD

Market perspective

The global Urinary and Pelvic Floor Health Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Urinary and Pelvic Floor Health Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Urinary and Pelvic Floor Health Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Urinary and Pelvic Floor Health Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Urinary and Pelvic Floor Health Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Urinary and Pelvic Floor Health Solution market include Peloton Health, Elvie, Renovia, InControl Medical, PeriCoach, NeoTract, NextGen Jane, Hollister Incorporated and Zimmer Biomet, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Urinary and Pelvic Floor Health Solution market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Urinary and Pelvic Floor Health Solution and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Urinary and Pelvic Floor Health Solution revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Urinary and Pelvic Floor Health Solution market.

Urinary and Pelvic Floor Health Solution Segment by Company

Peloton Health

Elvie

Renovia

InControl Medical

PeriCoach

NeoTract

NextGen Jane

Hollister Incorporated

Zimmer Biomet

Joylux

Medtronic

Atlantic Therapeutics

Boston Scientific

Urinary and Pelvic Floor Health Solution Segment by Type

Urology and Pelvic Floor Health Software

Urology and Pelvic Floor Health Service

Urinary and Pelvic Floor Health Solution Segment by Application

Male

Female

Urinary and Pelvic Floor Health Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Urinary and Pelvic Floor Health Solution status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Urinary and Pelvic Floor Health Solution key companies, revenue, market share, and recent developments.

3. To split the Urinary and Pelvic Floor Health Solution breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Urinary and Pelvic Floor Health Solution market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Urinary and Pelvic Floor Health Solution significant trends, drivers, influence factors in global and regions.

6. To analyze Urinary and Pelvic Floor Health Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urinary and Pelvic Floor Health Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urinary and Pelvic Floor Health Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urinary and Pelvic Floor Health Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Urinary and Pelvic Floor Health Solution industry.

Chapter 3: Detailed analysis of Urinary and Pelvic Floor Health Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Urinary and Pelvic Floor Health Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Urinary and Pelvic Floor Health Solution in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Urinary and Pelvic Floor Health Solution Industry Trends Table 2. Urinary and Pelvic Floor Health Solution Industry Drivers Table 3. Urinary and Pelvic Floor Health Solution Industry Opportunities and Challenges Table 4. Urinary and Pelvic Floor Health Solution Industry Restraints Table 5. Global Urinary and Pelvic Floor Health Solution Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Urinary and Pelvic Floor Health Solution Revenue Share by Company (2021-2026) Table 7. Global Urinary and Pelvic Floor Health Solution Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Urinary and Pelvic Floor Health Solution Key Company Manufacturing Base & Headquarters Table 9. Global Urinary and Pelvic Floor Health Solution Company, Product Type & Application Table 10. Global Urinary and Pelvic Floor Health Solution Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Urinary and Pelvic Floor Health Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Urology and Pelvic Floor Health Software Table 15. Significant Companies of Urology and Pelvic Floor Health Service Table 16. Global Urinary and Pelvic Floor Health Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Urinary and Pelvic Floor Health Solution Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Urinary and Pelvic Floor Health Solution Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Urinary and Pelvic Floor Health Solution Sales Value Share by Type (2021-2026) Table 20. Global Urinary and Pelvic Floor Health Solution Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Male Table 22. Significant Companies of Female Table 23. Global Urinary and Pelvic Floor Health Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Urinary and Pelvic Floor Health Solution Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Urinary and Pelvic Floor Health Solution Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Urinary and Pelvic Floor Health Solution Sales Value Share by Application (2021-2026) Table 27. Global Urinary and Pelvic Floor Health Solution Sales Value Share by Application (2027-2032) Table 28. Global Urinary and Pelvic Floor Health Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Urinary and Pelvic Floor Health Solution Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Urinary and Pelvic Floor Health Solution Sales Value Share by Region (2021-2026) Table 31. Global Urinary and Pelvic Floor Health Solution Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Urinary and Pelvic Floor Health Solution Sales Value Share by Region (2027-2032) Table 33. Global Urinary and Pelvic Floor Health Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Urinary and Pelvic Floor Health Solution Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Urinary and Pelvic Floor Health Solution Sales Value Market Share by Country (2021-2026) Table 36. Global Urinary and Pelvic Floor Health Solution Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Urinary and Pelvic Floor Health Solution Sales Value Market Share by Country (2027-2032) Table 38. Peloton Health Company Information Table 39. Peloton Health Business Overview Table 40. Peloton Health Urinary and Pelvic Floor Health Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Peloton Health Urinary and Pelvic Floor Health Solution Product Portfolio Table 42. Peloton Health Recent Development Table 43. Elvie Company Information Table 44. Elvie Business Overview Table 45. Elvie Urinary and Pelvic Floor Health Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Elvie Urinary and Pelvic Floor Health Solution Product Portfolio Table 47. Elvie Recent Development Table 48. Renovia Company Information Table 49. Renovia Business Overview Table 50. Renovia Urinary and Pelvic Floor Health Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Renovia Urinary and Pelvic Floor Health Solution Product Portfolio Table 52. Renovia Recent Development Table 53. InControl Medical Company Information Table 54. InControl Medical Business Overview Table 55. InControl Medical Urinary and Pelvic Floor Health Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. InControl Medical Urinary and Pelvic Floor Health Solution Product Portfolio Table 57. InControl Medical Recent Development Table 58. PeriCoach Company Information Table 59. PeriCoach Business Overview Table 60. PeriCoach Urinary and Pelvic Floor Health Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. PeriCoach Urinary and Pelvic Floor Health Solution Product Portfolio Table 62. PeriCoach Recent Development Table 63. NeoTract Company Information Table 64. NeoTract Business Overview Table 65. NeoTract Urinary and Pelvic Floor Health Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. NeoTract Urinary and Pelvic Floor Health Solution Product Portfolio Table 67. NeoTract Recent Development Table 68. NextGen Jane Company Information Table 69. NextGen Jane Business Overview Table 70. NextGen Jane Urinary and Pelvic Floor Health Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. NextGen Jane Urinary and Pelvic Floor Health Solution Product Portfolio Table 72. NextGen Jane Recent Development Table 73. Hollister Incorporated Company Information Table 74. Hollister Incorporated Business Overview Table 75. Hollister Incorporated Urinary and Pelvic Floor Health Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Hollister Incorporated Urinary and Pelvic Floor Health Solution Product Portfolio Table 77. Hollister Incorporated Recent Development Table 78. Zimmer Biomet Company Information Table 79. Zimmer Biomet Business Overview Table 80. Zimmer Biomet Urinary and Pelvic Floor Health Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Zimmer Biomet Urinary and Pelvic Floor Health Solution Product Portfolio Table 82. Zimmer Biomet Recent Development Table 83. Joylux Company Information Table 84. Joylux Business Overview Table 85. Joylux Urinary and Pelvic Floor Health Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Joylux Urinary and Pelvic Floor Health Solution Product Portfolio Table 87. Joylux Recent Development Table 88. Medtronic Company Information Table 89. Medtronic Business Overview Table 90. Medtronic Urinary and Pelvic Floor Health Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Medtronic Urinary and Pelvic Floor Health Solution Product Portfolio Table 92. Medtronic Recent Development Table 93. Atlantic Therapeutics Company Information Table 94. Atlantic Therapeutics Business Overview Table 95. Atlantic Therapeutics Urinary and Pelvic Floor Health Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Atlantic Therapeutics Urinary and Pelvic Floor Health Solution Product Portfolio Table 97. Atlantic Therapeutics Recent Development Table 98. Boston Scientific Company Information Table 99. Boston Scientific Business Overview Table 100. Boston Scientific Urinary and Pelvic Floor Health Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Boston Scientific Urinary and Pelvic Floor Health Solution Product Portfolio Table 102. Boston Scientific Recent Development Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Urinary and Pelvic Floor Health Solution Product Image Figure 2. Global Urinary and Pelvic Floor Health Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urinary and Pelvic Floor Health Solution Market Size (2021-2032) & (US$ Million) Figure 4. Global Urinary and Pelvic Floor Health Solution Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Urology and Pelvic Floor Health Software Image Figure 8. Urology and Pelvic Floor Health Service Image Figure 9. Global Urinary and Pelvic Floor Health Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Urinary and Pelvic Floor Health Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Urinary and Pelvic Floor Health Solution Sales Value Share by Type (2021-2032) Figure 12. Male Image Figure 13. Female Image Figure 14. Global Urinary and Pelvic Floor Health Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Urinary and Pelvic Floor Health Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Urinary and Pelvic Floor Health Solution Sales Value Share by Application (2021-2032) Figure 17. Global Urinary and Pelvic Floor Health Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Urinary and Pelvic Floor Health Solution Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Urinary and Pelvic Floor Health Solution Sales Value (2021-2032) & (US$ Million) Figure 20. North America Urinary and Pelvic Floor Health Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Urinary and Pelvic Floor Health Solution Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Urinary and Pelvic Floor Health Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Urinary and Pelvic Floor Health Solution Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Urinary and Pelvic Floor Health Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Urinary and Pelvic Floor Health Solution Sales Value (2021-2032) & (US$ Million) Figure 26. South America Urinary and Pelvic Floor Health Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Urinary and Pelvic Floor Health Solution Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Urinary and Pelvic Floor Health Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Urology and Pelvic Floor Health Software
  • Urology and Pelvic Floor Health Service
Applications
  • Male
  • Female
Companies covered
  • Peloton Health
  • Elvie
  • Renovia
  • InControl Medical
  • PeriCoach
  • NeoTract
  • NextGen Jane
  • Hollister Incorporated
  • Zimmer Biomet
  • Joylux
  • Medtronic
  • Atlantic Therapeutics
  • Boston Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Urinary and Pelvic Floor Health Solution Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Urinary and Pelvic Floor Health Solution Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Urinary and Pelvic Floor Health Solution Market Dynamics
  1. 2.1 Urinary and Pelvic Floor Health Solution Industry Trends
  2. 2.2 Urinary and Pelvic Floor Health Solution Industry Drivers
  3. 2.3 Urinary and Pelvic Floor Health Solution Industry Opportunities and Challenges
  4. 2.4 Urinary and Pelvic Floor Health Solution Industry Restraints
3 Urinary and Pelvic Floor Health Solution Market by Company
  1. 3.1 Global Urinary and Pelvic Floor Health Solution Company Revenue Ranking in 2025
  2. 3.2 Global Urinary and Pelvic Floor Health Solution Revenue by Company (2021-2026)
  3. 3.3 Global Urinary and Pelvic Floor Health Solution Company Ranking (2024-2026)
  4. 3.4 Global Urinary and Pelvic Floor Health Solution Company Manufacturing Base and Headquarters
  5. 3.5 Global Urinary and Pelvic Floor Health Solution Company Product Type and Application
  6. 3.6 Global Urinary and Pelvic Floor Health Solution Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Urinary and Pelvic Floor Health Solution Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Urinary and Pelvic Floor Health Solution Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Urinary and Pelvic Floor Health Solution Market by Type
  1. 4.1 Urinary and Pelvic Floor Health Solution Type Introduction
  2. 4.1.1 Urology and Pelvic Floor Health Software
  3. 4.1.2 Urology and Pelvic Floor Health Service
  4. 4.2 Global Urinary and Pelvic Floor Health Solution Sales Value by Type
  5. 4.2.1 Global Urinary and Pelvic Floor Health Solution Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Urinary and Pelvic Floor Health Solution Sales Value by Type (2021-2032)
  7. 4.2.3 Global Urinary and Pelvic Floor Health Solution Sales Value Share by Type (2021-2032)
5 Urinary and Pelvic Floor Health Solution Market by Application
  1. 5.1 Urinary and Pelvic Floor Health Solution Application Introduction
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Urinary and Pelvic Floor Health Solution Sales Value by Application
  5. 5.2.1 Global Urinary and Pelvic Floor Health Solution Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Urinary and Pelvic Floor Health Solution Sales Value by Application (2021-2032)
  7. 5.2.3 Global Urinary and Pelvic Floor Health Solution Sales Value Share by Application (2021-2032)
6 Urinary and Pelvic Floor Health Solution Regional Value Analysis
  1. 6.1 Global Urinary and Pelvic Floor Health Solution Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Urinary and Pelvic Floor Health Solution Sales Value by Region (2021-2032)
  3. 6.2.1 Global Urinary and Pelvic Floor Health Solution Sales Value by Region: 2021-2026
  4. 6.2.2 Global Urinary and Pelvic Floor Health Solution Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Urinary and Pelvic Floor Health Solution Sales Value (2021-2032)
  7. 6.3.2 North America Urinary and Pelvic Floor Health Solution Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Urinary and Pelvic Floor Health Solution Sales Value (2021-2032)
  10. 6.4.2 Europe Urinary and Pelvic Floor Health Solution Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Urinary and Pelvic Floor Health Solution Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Urinary and Pelvic Floor Health Solution Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Urinary and Pelvic Floor Health Solution Sales Value (2021-2032)
  16. 6.6.2 South America Urinary and Pelvic Floor Health Solution Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Urinary and Pelvic Floor Health Solution Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Urinary and Pelvic Floor Health Solution Sales Value Share by Country, 2025 VS 2032
7 Urinary and Pelvic Floor Health Solution Country-level Value Analysis
  1. 7.1 Global Urinary and Pelvic Floor Health Solution Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Urinary and Pelvic Floor Health Solution Sales Value by Country (2021-2032)
  3. 7.2.1 Global Urinary and Pelvic Floor Health Solution Sales Value by Country (2021-2026)
  4. 7.2.2 Global Urinary and Pelvic Floor Health Solution Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Urinary and Pelvic Floor Health Solution Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Urinary and Pelvic Floor Health Solution Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Urinary and Pelvic Floor Health Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Peloton Health
  2. 8.1.1 Peloton Health Company Information
  3. 8.1.2 Peloton Health Business Overview
  4. 8.1.3 Peloton Health Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Peloton Health Urinary and Pelvic Floor Health Solution Product Portfolio
  6. 8.1.5 Peloton Health Recent Developments
  7. 8.2 Elvie
  8. 8.2.1 Elvie Company Information
  9. 8.2.2 Elvie Business Overview
  10. 8.2.3 Elvie Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Elvie Urinary and Pelvic Floor Health Solution Product Portfolio
  12. 8.2.5 Elvie Recent Developments
  13. 8.3 Renovia
  14. 8.3.1 Renovia Company Information
  15. 8.3.2 Renovia Business Overview
  16. 8.3.3 Renovia Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Renovia Urinary and Pelvic Floor Health Solution Product Portfolio
  18. 8.3.5 Renovia Recent Developments
  19. 8.4 InControl Medical
  20. 8.4.1 InControl Medical Company Information
  21. 8.4.2 InControl Medical Business Overview
  22. 8.4.3 InControl Medical Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  23. 8.4.4 InControl Medical Urinary and Pelvic Floor Health Solution Product Portfolio
  24. 8.4.5 InControl Medical Recent Developments
  25. 8.5 PeriCoach
  26. 8.5.1 PeriCoach Company Information
  27. 8.5.2 PeriCoach Business Overview
  28. 8.5.3 PeriCoach Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PeriCoach Urinary and Pelvic Floor Health Solution Product Portfolio
  30. 8.5.5 PeriCoach Recent Developments
  31. 8.6 NeoTract
  32. 8.6.1 NeoTract Company Information
  33. 8.6.2 NeoTract Business Overview
  34. 8.6.3 NeoTract Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NeoTract Urinary and Pelvic Floor Health Solution Product Portfolio
  36. 8.6.5 NeoTract Recent Developments
  37. 8.7 NextGen Jane
  38. 8.7.1 NextGen Jane Company Information
  39. 8.7.2 NextGen Jane Business Overview
  40. 8.7.3 NextGen Jane Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  41. 8.7.4 NextGen Jane Urinary and Pelvic Floor Health Solution Product Portfolio
  42. 8.7.5 NextGen Jane Recent Developments
  43. 8.8 Hollister Incorporated
  44. 8.8.1 Hollister Incorporated Company Information
  45. 8.8.2 Hollister Incorporated Business Overview
  46. 8.8.3 Hollister Incorporated Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hollister Incorporated Urinary and Pelvic Floor Health Solution Product Portfolio
  48. 8.8.5 Hollister Incorporated Recent Developments
  49. 8.9 Zimmer Biomet
  50. 8.9.1 Zimmer Biomet Company Information
  51. 8.9.2 Zimmer Biomet Business Overview
  52. 8.9.3 Zimmer Biomet Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zimmer Biomet Urinary and Pelvic Floor Health Solution Product Portfolio
  54. 8.9.5 Zimmer Biomet Recent Developments
  55. 8.10 Joylux
  56. 8.10.1 Joylux Company Information
  57. 8.10.2 Joylux Business Overview
  58. 8.10.3 Joylux Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Joylux Urinary and Pelvic Floor Health Solution Product Portfolio
  60. 8.10.5 Joylux Recent Developments
  61. 8.11 Medtronic
  62. 8.11.1 Medtronic Company Information
  63. 8.11.2 Medtronic Business Overview
  64. 8.11.3 Medtronic Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Medtronic Urinary and Pelvic Floor Health Solution Product Portfolio
  66. 8.11.5 Medtronic Recent Developments
  67. 8.12 Atlantic Therapeutics
  68. 8.12.1 Atlantic Therapeutics Company Information
  69. 8.12.2 Atlantic Therapeutics Business Overview
  70. 8.12.3 Atlantic Therapeutics Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Atlantic Therapeutics Urinary and Pelvic Floor Health Solution Product Portfolio
  72. 8.12.5 Atlantic Therapeutics Recent Developments
  73. 8.13 Boston Scientific
  74. 8.13.1 Boston Scientific Company Information
  75. 8.13.2 Boston Scientific Business Overview
  76. 8.13.3 Boston Scientific Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Boston Scientific Urinary and Pelvic Floor Health Solution Product Portfolio
  78. 8.13.5 Boston Scientific Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst